| Product Code: ETC9512599 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Suriname gemcitabine HCl import market in 2024 saw significant contributions from top exporting countries like the Netherlands, India, Germany, Hong Kong, and Guyana. The market concentration, as measured by the HHI, remained high, indicating a dominant presence of these key players. The compound annual growth rate (CAGR) from 2020 to 2024 stood at 2.21%, with a growth rate of 2.02% from 2023 to 2024, reflecting a steady upward trend in the import shipments of gemcitabine HCl into Suriname.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Suriname Gemcitabine HCL Market Overview |
3.1 Suriname Country Macro Economic Indicators |
3.2 Suriname Gemcitabine HCL Market Revenues & Volume, 2021 & 2031F |
3.3 Suriname Gemcitabine HCL Market - Industry Life Cycle |
3.4 Suriname Gemcitabine HCL Market - Porter's Five Forces |
3.5 Suriname Gemcitabine HCL Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Suriname Gemcitabine HCL Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Suriname Gemcitabine HCL Market Revenues & Volume Share, By End-user, 2021 & 2031F |
4 Suriname Gemcitabine HCL Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in Suriname |
4.2.2 Growing investments in healthcare infrastructure |
4.2.3 Rising demand for effective chemotherapy drugs |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval |
4.3.2 High cost associated with research and development of new drugs |
4.3.3 Limited availability of skilled healthcare professionals in Suriname |
5 Suriname Gemcitabine HCL Market Trends |
6 Suriname Gemcitabine HCL Market, By Types |
6.1 Suriname Gemcitabine HCL Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Suriname Gemcitabine HCL Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Suriname Gemcitabine HCL Market Revenues & Volume, By Branded, 2021- 2031F |
6.1.4 Suriname Gemcitabine HCL Market Revenues & Volume, By Generic, 2021- 2031F |
6.2 Suriname Gemcitabine HCL Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Suriname Gemcitabine HCL Market Revenues & Volume, By Pancreatic Cancer, 2021- 2031F |
6.2.3 Suriname Gemcitabine HCL Market Revenues & Volume, By Breast Cancer, 2021- 2031F |
6.2.4 Suriname Gemcitabine HCL Market Revenues & Volume, By Ovarian Cancer, 2021- 2031F |
6.2.5 Suriname Gemcitabine HCL Market Revenues & Volume, By Non-small Cell Lung Carcinoma (NSCLC), 2021- 2031F |
6.2.6 Suriname Gemcitabine HCL Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Suriname Gemcitabine HCL Market, By End-user |
6.3.1 Overview and Analysis |
6.3.2 Suriname Gemcitabine HCL Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 Suriname Gemcitabine HCL Market Revenues & Volume, By Cancer Centers, 2021- 2031F |
6.3.4 Suriname Gemcitabine HCL Market Revenues & Volume, By Others, 2021- 2031F |
7 Suriname Gemcitabine HCL Market Import-Export Trade Statistics |
7.1 Suriname Gemcitabine HCL Market Export to Major Countries |
7.2 Suriname Gemcitabine HCL Market Imports from Major Countries |
8 Suriname Gemcitabine HCL Market Key Performance Indicators |
8.1 Number of clinical trials involving gemcitabine HCl in Suriname |
8.2 Adoption rate of gemcitabine HCl in cancer treatment protocols |
8.3 Patient satisfaction levels with gemcitabine HCl efficacy and side effects profile |
9 Suriname Gemcitabine HCL Market - Opportunity Assessment |
9.1 Suriname Gemcitabine HCL Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Suriname Gemcitabine HCL Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Suriname Gemcitabine HCL Market Opportunity Assessment, By End-user, 2021 & 2031F |
10 Suriname Gemcitabine HCL Market - Competitive Landscape |
10.1 Suriname Gemcitabine HCL Market Revenue Share, By Companies, 2024 |
10.2 Suriname Gemcitabine HCL Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here